18 May 2013
Keywords: inspire, drops, out, accord, faes, farma, bilastine
Article | 21 January 2008
The USA's Inspire Pharmaceuticals has exercised its option to terminate the licensing agreement with Spanish drugmaker FAES Farma SA
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 January 2008
17 May 2013
© 2013 thepharmaletter.com